Circadian influences on myocardial infarction

Frontiers in Physiology

Volumn 5, Issue OCT, 2014, Pages

  Virag, Jitka ^a   Lust, Robert ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRYPTOCHROME 1; CRYPTOCHROME 2; GRANULOCYTE COLONY STIMULATING FACTOR; HYPOXIA INDUCIBLE FACTOR 1ALPHA; INTERLEUKIN 1; MELATONIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PER1 PROTEIN; PER2 PROTEIN; PROTEIN BMAL1; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR CLOCK;

BLOOD PRESSURE; CIRCADIAN RHYTHM; CLOCK GENE; CYTOKINE RELEASE; GENE EXPRESSION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HUMAN; INFLAMMATION; ISCHEMIC PRECONDITIONING; LIGHT DARK CYCLE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATIVE STRESS; REPERFUSION INJURY; REVIEW; SHIFT WORKER; SUPRACHIASMATIC NUCLEUS;

EID: 84908364546     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00422     Document Type: Review

References (186)

1. Albert, M.A. (2000). The role of C-reactive protein in cardiovascular disease risk. Curr Cardiol Rep 2, 274-279
2. Albert, M.A., Glynn, R.J., and Ridker, P.M. (2003). Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score. Circulation 108, 161-165
3. Alibhai, F.J., Tsimakouridze, E.V., Chinnappareddy, N., Wright, D.C., Billia, F., O'sullivan, M.L., Pyle, W.G., Sole, M.J., and Martino, T.A. (2014). Short-term disruption of diurnal rhythms after murine myocardial infarction adversely affects long-term myocardial structure and function. Circ Res 114, 1713-1722. doi: 10.1161/CIRCRESAHA.114.302995
4. Anaya-Prado, R., Toledo-Pereyra, L.H., Lentsch, A.B., and Ward, P.A. (2002). Ischemia/reperfusion injury. J Surg Res 105, 248-258
5. Aydogan, S., Yerer, M.B., and Goktas, A. (2006). Melatonin and nitric oxide. J Endocrinol Invest 29, 281-287
6. Bailey, S.M., Udoh, U.S., and Young, M.E. (2014). Circadian regulation of metabolism. J Endocrinol 222, R75-R96. doi: 10.1530/JOE-14-0200
7. Balsalobre, A., Brown, S.A., Marcacci, L., Tronche, F., Kellendonk, C., Reichardt, H.M., Schutz, G., and Schibler, U. (2000). Resetting of circadian time in peripheral tissues by glucocorticoid signaling. Science 289, 2344-2347
8. Baroldi, G. (1988). Anatomy and quantification of myocardial cell death. Methods Achiev Exp Pathol 13, 87-113
9. Bonney, S., Hughes, K., Harter, P.N., Mittelbronn, M., Walker, L., and Eckle, T. (2013a). Cardiac period 2 in myocardial ischemia: clinical implications of a light dependent protein. Int J Biochem Cell Biol 45, 667-671. doi: 10.1016/j.biocel.2012.12.022
10. Bonney, S., Kominsky, D., Brodsky, K., Eltzschig, H., Walker, L., and Eckle, T. (2013b). Cardiac Per2 functions as novel link between fatty acid metabolism and myocardial inflammation during ischemia and reperfusion injury of the heart. PLoS One 8, e71493. doi: 10.1371/journal.pone.0071493
11. Bourin, P., Ledain, A.F., Beau, J., Mille, D., and Levi, F. (2002). In-vitro circadian rhythm of murine bone marrow progenitor production. Chronobiol Int 19, 57-67
12. Bray, M.S., and Young, M.E. (2007). Circadian rhythms in the development of obesity: potential role for the circadian clock within the adipocyte. Obes Rev 8, 169-181. doi: OBR277 [pii] 10.1111/j.1467-789X.2006.00277.x
13. Byrne, J.A., Grieve, D.J., Cave, A.C., and Shah, A.M. (2003). Oxidative stress and heart failure. Arch Mal Coeur Vaiss 96, 214-221
14. Chandrasekar, B., Colston, J.T., De La Rosa, S.D., Rao, P.P., and Freeman, G.L. (2003). TNF-alpha and H2O2 induce IL-18 and IL-18R beta expression in cardiomyocytes via NF-kappa B activation. Biochem Biophys Res Commun 303, 1152-1158
15. Chintalgattu, V., and Katwa, L.C. (2004). Role of protein kinase Cdelta in endothelin-induced type I collagen expression in cardiac myofibroblasts isolated from the site of myocardial infarction. J Pharmacol Exp Ther 311, 691-699
16. Chu, L.W., Zhu, Y., Yu, K., Zheng, T., Yu, H., Zhang, Y., Sesterhenn, I., Chokkalingam, A.P., Danforth, K.N., Shen, M.C., Stanczyk, F.Z., Gao, Y.T., and Hsing, A.W. (2008). Variants in circadian genes and prostate cancer risk: a population-based study in China. Prostate Cancer Prostatic Dis 11, 342-348. doi: 4501024 [pii]
17. Clairambault, J. (2008). A step toward optimization of cancer therapeutics. Physiologically based modeling of circadian control on cell proliferation. IEEE Eng Med Biol Mag 27, 20-24. doi: 10.1109/MEMB.2007.907363
18. Cleutjens, J.P., Kandala, J.C., Guarda, E., Guntaka, R.V., and Weber, K.T. (1995). Regulation of collagen degradation in the rat myocardium after infarction. J Mol Cell Cardiol 27, 1281-1292
19. Cohen, M.V., Yang, X.M., and Downey, J.M. (2006). Nitric oxide is a preconditioning mimetic and cardioprotectant and is the basis of many available infarct-sparing strategies. Cardiovasc Res 70, 231-239
20. Cohen, R.A. (1995). The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease. Prog Cardiovasc Dis 38, 105-128
21. Corwin, J.V., and Vargo, J.M. (1993). Light deprivation produces accelerated behavioral recovery of function from neglect produced by unilateral medial agranular prefrontal cortex lesions in rats. Behav Brain Res 56, 187-196
22. Costa, A.D., and Garlid, K.D. (2008). Intramitochondrial signaling: interactions among mitoKATP, PKCepsilon, ROS, and MPT. Am J Physiol Heart Circ Physiol 295, H874-882. doi: 01189.2007 [pii] 10.1152/ajpheart.01189.2007
23. Costa, A.D., Garlid, K.D., West, I.C., Lincoln, T.M., Downey, J.M., Cohen, M.V., and Critz, S.D. (2005). Protein kinase G transmits the cardioprotective signal from cytosol to mitochondria. Circ Res 97, 329-336. doi: 01.RES.0000178451.08719.5b [pii] 10.1161/01.RES.0000178451.08719.5b.
24. Cozzi, E., Hazarika, S., Stallings, H.W., 3rd, Cascio, W.E., Devlin, R.B., Lust, R.M., Wingard, C.J., and Van Scott, M.R. (2006). Ultrafine particulate matter exposure augments ischemia-reperfusion injury in mice. Am J Physiol Heart Circ Physiol 291, H894-903
25. Crisostomo, P.R., Wairiuko, G.M., Wang, M., Tsai, B.M., Morrell, E.D., and Meldrum, D.R. (2006). Preconditioning versus postconditioning: mechanisms and therapeutic potentials. J Am Coll Surg 202, 797-812
26. Curtis, A.M., Bellet, M.M., Sassone-Corsi, P., and O'neill, L.A. (2014). Circadian clock proteins and immunity. Immunity 40, 178-186. doi: 10.1016/j.immuni.2014.02.002
27. Dardente, H., and Cermakian, N. (2005). [How many pieces to build a circadian clock?]. Med Sci (Paris) 21, 66-72
28. Das, S., Wong, R., Rajapakse, N., Murphy, E., and Steenbergen, C. (2008). Glycogen synthase kinase 3 inhibition slows mitochondrial adenine nucleotide transport and regulates voltage-dependent anion channel phosphorylation. Circ Res 103, 983-991. doi: CIRCRESAHA.108.178970 [pii] 10.1161/CIRCRESAHA.108.178970
29. Date, T., Mochizuki, S., Belanger, A.J., Yamakawa, M., Luo, Z., Vincent, K.A., Cheng, S.H., Gregory, R.J., and Jiang, C. (2005). Expression of constitutively stable hybrid hypoxia-inducible factor-1alpha protects cultured rat cardiomyocytes against simulated ischemia-reperfusion injury. Am J Physiol Cell Physiol 288, C314-320
30. Davidson, A.J., London, B., Block, G.D., and Menaker, M. (2005). Cardiovascular tissues contain independent circadian clocks. Clin Exp Hypertens 27, 307-311
31. De Luca, G., Suryapranata, H., Ottervanger, J.P., Van't Hof, A.W., Hoorntje, J.C., Gosselink, A.T., Dambrink, J.H., Zijlstra, F., and De Boer, M.J. (2005). Circadian variation in myocardial perfusion and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty. Am Heart J 150, 1185-1189
32. Decoursey, P.J., Walker, J.K., and Smith, S.A. (2000). A circadian pacemaker in free-living chipmunks: essential for survival? J Comp Physiol [A] 186, 169-180
33. Di Lisa, F., Canton, M., Menabo, R., Kaludercic, N., and Bernardi, P. (2007). Mitochondria and cardioprotection. Heart Fail Rev 12, 249-260. doi: 10.1007/s10741-007-9028-z
34. Di Lisa, F., Menabo, R., Canton, M., and Petronilli, V. (1998). The role of mitochondria in the salvage and the injury of the ischemic myocardium. Biochim Biophys Acta 1366, 69-78
35. Ding, J.M., Chen, D., Weber, E.T., Faiman, L.E., Rea, M.A., and Gillette, M.U. (1994). Resetting the biological clock: mediation of nocturnal circadian shifts by glutamate and NO. Science 266, 1713-1717
36. Dominguez-Rodriguez, A., Abreu-Gonzalez, P., Garcia-Gonzalez, M., and Reiter, R.J. (2006a). Prognostic value of nocturnal melatonin levels as a novel marker in patients with ST-segment elevation myocardial infarction. Am J Cardiol 97, 1162-1164
37. Dominguez-Rodriguez, A., Garcia-Gonzalez, M., Abreu-Gonzalez, P., Ferrer, J., and Kaski, J.C. (2006b). Relation of nocturnal melatonin levels to C-reactive protein concentration in patients with STsegment elevation myocardial infarction. Am J Cardiol 97, 10-12
38. Durgan, D.J., Hotze, M.A., Tomlin, T.M., Egbejimi, O., Graveleau, C., Abel, E.D., Shaw, C.A., Bray, M.S., Hardin, P.E., and Young, M.E. (2005). The intrinsic circadian clock within the cardiomyocyte. Am J Physiol Heart Circ Physiol 289, H1530-1541
39. Durgan, D.J., and Young, M.E. (2010). The cardiomyocyte circadian clock: emerging roles in health and disease. Circ Res 106, 647-658. doi: 10.1161/CIRCRESAHA.109.209957
40. Dvornyk, V., Vinogradova, O., and Nevo, E. (2003). Origin and evolution of circadian clock genes in prokaryotes. Proc Natl Acad Sci U S A 100, 2495-2500
41. Eckle, T., Hartmann, K., Bonney, S., Reithel, S., Mittelbronn, M., Walker, L.A., Lowes, B.D., Han, J., Borchers, C.H., Buttrick, P.M., Kominsky, D.J., Colgan, S.P., and Eltzschig, H.K. (2012). Adora2belicited Per2 stabilization promotes a HIF-dependent metabolic switch crucial for myocardial adaptation to ischemia. Nat Med 18, 774-782. doi: 10.1038/nm.2728
42. Eltzschig, H.K., Bonney, S.K., and Eckle, T. (2013). Attenuating myocardial ischemia by targeting A2B adenosine receptors. Trends Mol Med 19, 345-354. doi: 10.1016/j.molmed.2013.02.005
43. Frangogiannis, N.G. (2006). The mechanistic basis of infarct healing. Antioxid Redox Signal 8, 1907-1939. doi: 10.1089/ars.2006.8.1907
44. Frangogiannis, N.G., and Entman, M.L. (2005). Chemokines in myocardial ischemia. Trends Cardiovasc Med 15, 163-169. doi: 10.1016/j.tcm.2005.06.005
45. Frangogiannis, N.G., Smith, C.W., and Entman, M.L. (2002). The inflammatory response in myocardial infarction. Cardiovascular Research 53, 31-47
46. Frangogiannis, N.G., Youker, K.A., and Entman, M.L. (1996). The role of the neutrophil in myocardial ischemia and reperfusion. EXS 76, 263-284
47. Fujino, Y., Iso, H., Tamakoshi, A., Inaba, Y., Koizumi, A., Kubo, T., and Yoshimura, T. (2006). A prospective cohort study of shift work and risk of ischemic heart disease in Japanese male workers. Am J Epidemiol 164, 128-135
48. Fukuhara, C., and Tosini, G. (2003). Peripheral circadian oscillators and their rhythmic regulation. Front Biosci 8, d642-651
49. Garlid, K.D., Costa, A.D., Quinlan, C.L., Pierre, S.V., and Dos Santos, P. (2009). Cardioprotective signaling to mitochondria. J Mol Cell Cardiol 46, 858-866. doi: S0022-2828(08)01438-7 [pii] 10.1016/j.yjmcc.2008.11.019
50. Genade, S., Ytrehus, K., and Lochner, A. (2006). Melatonin prevents cardioprotection induced by a multicycle ischaemic preconditioning protocol in the isolated perfused rat heart. Cardiovasc J S Afr 17, 239-244
51. Ghorbel, M.T., Coulson, J.M., and Murphy, D. (2003). Cross-talk between hypoxic and circadian pathways: cooperative roles for hypoxia-inducible factor 1alpha and CLOCK in transcriptional activation of the vasopressin gene. Mol Cell Neurosci 22, 396-404
52. Giordano, F.J. (2005). Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 115, 500-508
53. Glossop, N.R., Lyons, L.C., and Hardin, P.E. (1999). Interlocked feedback loops within the Drosophila circadian oscillator. Science 286, 766-768
54. Granados-Fuentes, D., and Herzog, E.D. (2013). The clock shop: coupled circadian oscillators. Exp Neurol 243, 21-27. doi: 10.1016/j.expneurol.2012.10.011
55. Granda, T.G., Liu, X.H., Smaaland, R., Cermakian, N., Filipski, E., Sassone-Corsi, P., and Levi, F. (2005). Circadian regulation of cell cycle and apoptosis proteins in mouse bone marrow and tumor. Faseb J 19, 304-306
56. Green, C.B., Takahashi, J.S., and Bass, J. (2008). The meter of metabolism. Cell 134, 728-742. doi: 10.1016/j.cell.2008.08.022
57. Gross, E.R., Hsu, A.K., and Gross, G.J. (2004). Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts. Circ Res 94, 960-966. doi: 10.1161/01.RES.0000122392.33172.09 01.RES.0000122392.33172.09 [pii]
58. Gross, E.R., Hsu, A.K., and Gross, G.J. (2006). The JAK/STAT pathway is essential for opioid-induced cardioprotection: JAK2 as a mediator of STAT3, Akt, and GSK-3 beta. Am J Physiol Heart Circ Physiol 291, H827-834. doi: 00003.2006 [pii] 10.1152/ajpheart.00003.2006
59. Gross, E.R., Hsu, A.K., and Gross, G.J. (2007). GSK3beta inhibition and K(ATP) channel opening mediate acute opioid-induced cardioprotection at reperfusion. Basic Res Cardiol 102, 341-349. doi: 10.1007/s00395-007-0651-6
60. Guillaumond, F., Dardente, H., Giguere, V., and Cermakian, N. (2005). Differential control of Bmal1 circadian transcription by REV-ERB and ROR nuclear receptors. J Biol Rhythms 20, 391-403. doi: 10.1177/0748730405277232
61. Guo, H., Brewer, J.M., Champhekar, A., Harris, R.B., and Bittman, E.L. (2005). Differential control of peripheral circadian rhythms by suprachiasmatic-dependent neural signals. Proc Natl Acad Sci U S A 102, 3111-3116
62. Gupta, A., and Shetty, H. (2005). Circadian variation in stroke - a prospective hospital-based study. Int J Clin Pract 59, 1272-1275
63. Hamacher-Brady, A., Brady, N.R., and Gottlieb, R.A. (2006). The interplay between pro-death and prosurvival signaling pathways in myocardial ischemia/reperfusion injury: apoptosis meets autophagy. Cardiovasc Drugs Ther 20, 445-462. doi: 10.1007/s10557-006-0583-7
64. Hardeland, R., Coto-Montes, A., and Poeggeler, B. (2003). Circadian rhythms, oxidative stress, and antioxidative defense mechanisms. Chronobiol Int 20, 921-962
65. Hardin, P.E. (2006). Essential and expendable features of the circadian timekeeping mechanism. Curr Opin Neurobiol 16, 686-692
66. Hardin, P.E., and Glossop, N.R. (1999). Perspectives: neurobiology. The CRYs fo flies and mice. Science 286, 2460-2461
67. Hardin, P.E., and Panda, S. (2013). Circadian timekeeping and output mechanisms in animals. Curr Opin Neurobiol 23, 724-731. doi: 10.1016/j.conb.2013.02.018
68. Harmer, S.L., Panda, S., and Kay, S.A. (2001). Molecular bases of circadian rhythms. Annu Rev Cell Dev Biol 17, 215-253
69. Hausenloy, D.J., Tsang, A., and Yellon, D.M. (2005). The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. Trends Cardiovasc Med 15, 69-75
70. Hazarika, S., Van Scott, M.R., and Lust, R.M. (2004). Myocardial ischemia-reperfusion injury is enhanced in a model of systemic allergy and asthma. Am J Physiol Heart Circ Physiol 286, H1720-1725
71. Herzog, E.D., and Schwartz, W.J. (2002). A neural clockwork for encoding circadian time. J Appl Physiol 92, 401-408
72. Holmes, J.W., Borg, T.K., and Covell, J.W. (2005). Structure and mechanics of healing myocardial infarcts. Annu Rev Biomed Eng 7, 223-253
73. Honma, S., Ikeda, M., Abe, H., Tanahashi, Y., Namihira, M., Honma, K., and Nomura, M. (1998). Circadian oscillation of BMAL1, a partner of a mammalian clock gene Clock, in rat suprachiasmatic nucleus. Biochem Biophys Res Commun 250, 83-87
74. Izzedine, H., Launay-Vacher, V., and Deray, G. (2006). Abnormal blood pressure circadian rhythm: a target organ damage? Int J Cardiol 107, 343-349
75. Jeyaraj, D., Haldar, S.M., Wan, X., Mccauley, M.D., Ripperger, J.A., Hu, K., Lu, Y., Eapen, B.L., Sharma, N., Ficker, E., Cutler, M.J., Gulick, J., Sanbe, A., Robbins, J., Demolombe, S., Kondratov, R.V., Shea, S.A., Albrecht, U., Wehrens, X.H., Rosenbaum, D.S., and Jain, M.K. (2012). Circadian rhythms govern cardiac repolarization and arrhythmogenesis. Nature 483, 96-99. doi: 10.1038/nature10852
76. Jilma, B., Hergovich, N., Stohlawetz, P., Eichler, H.G., Bauer, P., and Wagner, O.F. (1999). Circadian variation of granulocyte colony stimulating factor levels in man. Br J Haematol 106, 368-370. doi: bjh1543 [pii]
77. Jones, S.P., and Bolli, R. (2006). The ubiquitous role of nitric oxide in cardioprotection. J Mol Cell Cardiol 40, 16-23
78. Jones, S.P., Girod, W.G., Granger, D.N., Palazzo, A.J., and Lefer, D.J. (1999). Reperfusion injury is not affected by blockade of P-selectin in the diabetic mouse heart. Am J Physiol 277, H763-769
79. Jordan, J.E., Zhao, Z.Q., and Vinten-Johansen, J. (1999). The role of neutrophils in myocardial ischemiareperfusion injury. Cardiovasc Res 43, 860-878
80. Kaminski, K.A., Bonda, T.A., Korecki, J., and Musial, W.J. (2002). Oxidative stress and neutrophil activation--the two keystones of ischemia/reperfusion injury. Int J Cardiol 86, 41-59
81. Kanth, R., Ittaman, S., and Rezkalla, S. (2013). Circadian patterns of ST elevation myocardial infarction in the new millennium. Clin Med Res 11, 66-72. doi: 10.3121/cmr.2013.1120
82. Kawachi, I., Colditz, G.A., Stampfer, M.J., Willett, W.C., Manson, J.E., Speizer, F.E., and Hennekens, C.H. (1995). Prospective study of shift work and risk of coronary heart disease in women. Circulation 92, 3178-3182
83. Kawano, H., and Ogawa, H. (2005). Endothelial function and coronary spastic angina. Intern Med 44, 91-99
84. Knutsson, A., Akerstedt, T., Jonsson, B.G., and Orth-Gomer, K. (1986). Increased risk of ischaemic heart disease in shift workers. Lancet 2, 89-92
85. Koyanagi, S., Kuramoto, Y., Nakagawa, H., Aramaki, H., Ohdo, S., Soeda, S., and Shimeno, H. (2003). A molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells. Cancer Res 63, 7277-7283
86. Krieg, T., Cohen, M.V., and Downey, J.M. (2003). Mitochondria and their role in preconditioning's trigger phase. Basic Res Cardiol 98, 228-234
87. Kumar, D., and Jugdutt, B.I. (2003). Apoptosis and oxidants in the heart. J Lab Clin Med 142, 288-297
88. Kume, K., Zylka, M.J., Sriram, S., Shearman, L.P., Weaver, D.R., Jin, X., Maywood, E.S., Hastings, M.H., and Reppert, S.M. (1999). mCRY1 and mCRY2 are essential components of the negative limb of the circadian clock feedback loop. Cell 98, 193-205
89. Kyriacou, C.P., and Hall, J.C. (1980). Circadian rhythm mutations in Drosophila melanogaster affect shortterm fluctuations in the male's courtship song. Proc Natl Acad Sci U S A 77, 6729-6733
90. Lapenna, D., De Gioia, S., Mezzetti, A., Porreca, E., Ciofani, G., Marzio, L., Capani, F., Di Ilio, C., and Cuccurullo, F. (1992). Circadian variations in antioxidant defences and lipid peroxidation in the rat heart. Free Radic Res Commun 17, 187-194
91. Lee, C., Etchegaray, J.P., Cagampang, F.R., Loudon, A.S., and Reppert, S.M. (2001). Posttranslational mechanisms regulate the mammalian circadian clock. Cell 107, 855-867
92. Lee, K.W., Blann, A.D., and Lip, G.Y. (2005). High pulse pressure and nondipping circadian blood pressure in patients with coronary artery disease: Relationship to thrombogenesis and endothelial damage/dysfunction. Am J Hypertens 18, 104-115
93. Lemmer, B. (2006). The importance of circadian rhythms on drug response in hypertension and coronary heart disease--from mice and man. Pharmacol Ther 111, 629-651
94. Lipkova, J., Splichal, Z., Bienertova-Vasku, J.A., Jurajda, M., Parenica, J., Vasku, A., and Goldbergova, M.P. (2014). Period3 VNTR polymorphism influences the time-of-day pain onset of acute myocardial infarction with ST elevation. Chronobiol Int, 1-13. doi: 10.3109/07420528.2014.921790
95. Liu, J., Mankani, G., Shi, X., Meyer, M., Cunningham-Runddles, S., Ma, X., and Sun, Z.S. (2006). The circadian clock Period 2 gene regulates gamma interferon production of NK cells in host response to lipopolysaccharide-induced endotoxic shock. Infect Immun 74, 4750-4756
96. Lopez, F., Lee, K.W., Marin, F., Roldan, V., Sogorb, F., Caturla, J., and Lip, G.Y. (2005). Are there ethnic differences in the circadian variation in onset of acute myocardial infarction? A comparison of 3 ethnic groups in Birmingham, UK and Alicante, Spain. Int J Cardiol 100, 151-154
97. Lyle, A.N., and Griendling, K.K. (2006). Modulation of vascular smooth muscle signaling by reactive oxygen species. Physiology (Bethesda) 21, 269-280
98. Marin-Garcia, J., and Goldenthal, M.J. (2004). Mitochondria play a critical role in cardioprotection. J Card Fail 10, 55-66. doi: S1071916403001295 [pii]
99. Martino, T.A., Oudit, G.Y., Herzenberg, A.M., Tata, N., Koletar, M.M., Kabir, G.M., Belsham, D.D., Backx, P.H., Ralph, M.R., and Sole, M.J. (2008). Circadian rhythm disorganization produces profound cardiovascular and renal disease in hamsters. Am J Physiol Regul Integr Comp Physiol 294, R1675-1683
100. Martino, T.A., Tata, N., Belsham, D.D., Chalmers, J., Straume, M., Lee, P., Pribiag, H., Khaper, N., Liu, P.P., Dawood, F., Backx, P.H., Ralph, M.R., and Sole, M.J. (2007). Disturbed diurnal rhythm alters gene expression and exacerbates cardiovascular disease with rescue by resynchronization. Hypertension 49, 1104-1113. doi: 10.1161/HYPERTENSIONAHA.106.083568
101. Mattson, M.P., and Kroemer, G. (2003). Mitochondria in cell death: novel targets for neuroprotection and cardioprotection. Trends Mol Med 9, 196-205. doi: S1471491403000467 [pii]
102. Maulik, N. (2006). Reactive oxygen species drives myocardial angiogenesis? Antioxid Redox Signal 8, 2161-2168
103. Maury, E., Ramsey, K.M., and Bass, J. (2010). Circadian rhythms and metabolic syndrome: from experimental genetics to human disease. Circ Res 106, 447-462. doi: 10.1161/CIRCRESAHA.109.208355
104. Maywood, E.S., Fraenkel, E., Mcallister, C.J., Wood, N., Reddy, A.B., Hastings, M.H., and Morton, A.J. (2010). Disruption of peripheral circadian timekeeping in a mouse model of Huntington's disease and its restoration by temporally scheduled feeding. J Neurosci 30, 10199-10204. doi: 10.1523/JNEUROSCI.1694-10.2010
105. Mcnamara, P., Seo, S.P., Rudic, R.D., Sehgal, A., Chakravarti, D., and Fitzgerald, G.A. (2001). Regulation of CLOCK and MOP4 by nuclear hormone receptors in the vasculature: a humoral mechanism to reset a peripheral clock. Cell 105, 877-889
106. Mendez-Ferrer, S., Lucas, D., Battista, M., and Frenette, P.S. (2008). Haematopoietic stem cell release is regulated by circadian oscillations. Nature 452, 442-447. doi: nature06685 [pii] 10.1038/nature06685
107. Merrow, M., Spoelstra, K., and Roenneberg, T. (2005). The circadian cycle: daily rhythms from behaviour to genes. EMBO Rep 6, 930-935
108. Morgan, T.O. (2002). Is non-dipping status a predictor of cardiac morbidity? J Hypertens 20, 1469-1471
109. Mormont, M.C., Waterhouse, J., Bleuzen, P., Giacchetti, S., Jami, A., Bogdan, A., Lellouch, J., Misset, J.L., Touitou, Y., and Levi, F. (2000). Marked 24-h rest/activity rhythms are associated with better quality of life, better response, and longer survival in patients with metastatic colorectal cancer and good performance status. Clin Cancer Res 6, 3038-3045
110. Mosendane, T., and Raal, F.J. (2008). Shift work and its effects on the cardiovascular system. Cardiovasc J Afr 19, 210-215
111. Mozaffari, M.S., and Schaffer, S.W. (2008). Effect of pressure overload on cardioprotection of mitochondrial KATP channels and GSK-3beta: interaction with the MPT pore. Am J Hypertens 21, 570-575. doi: ajh200825 [pii] 10.1038/ajh.2008.25
112. Mukamal, K.J., Muller, J.E., Maclure, M., Sherwood, J.B., and Mittleman, M.A. (2000). Increased risk of congestive heart failure among infarctions with nighttime onset. Am Heart J 140, 438-442
113. Muller, J.E. (1999a). Circadian variation and triggering of acute coronary events. Am Heart J 137, S1-S8
114. Muller, J.E. (1999b). Circadian variation in cardiovascular events. Am J Hypertens 12, 35S-42S
115. Murphy, E. (2004). Inhibit GSK-3beta or there's heartbreak dead ahead. J Clin Invest 113, 1526-1528. doi: 10.1172/JCI21986
116. Murphy, E., and Steenbergen, C. (2005). Inhibition of GSK-3beta as a target for cardioprotection: the importance of timing, location, duration and degree of inhibition. Expert Opin Ther Targets 9, 447-456. doi: 10.1517/14728222.9.3.447
117. Murphy, E., and Steenbergen, C. (2007). Preconditioning: the mitochondrial connection. Annu Rev Physiol 69, 51-67. doi: 10.1146/annurev.physiol.69.031905.163645
118. Nagoshi, E., Brown, S.A., Dibner, C., Kornmann, B., and Schibler, U. (2005). Circadian gene expression in cultured cells. Methods Enzymol 393, 543-557
119. Nagoshi, E., Saini, C., Bauer, C., Laroche, T., Naef, F., and Schibler, U. (2004). Circadian gene expression in individual fibroblasts: cell-autonomous and self-sustained oscillators pass time to daughter cells. Cell 119, 693-705
120. Naito, Y., Tsujino, T., Kawasaki, D., Okumura, T., Morimoto, S., Masai, M., Sakoda, T., Fujioka, Y., Ohyanagi, M., and Iwasaki, T. (2003). Circadian gene expression of clock genes and plasminogen activator inhibitor-1 in heart and aorta of spontaneously hypertensive and Wistar-Kyoto rats. J Hypertens 21, 1107-1115
121. Nedeltcheva, A.V., and Scheer, F.A. (2014). Metabolic effects of sleep disruption, links to obesity and diabetes. Curr Opin Endocrinol Diabetes Obes 21, 293-298. doi: 10.1097/MED.0000000000000082
122. Nian, M., Lee, P., Khaper, N., and Liu, P. (2004). Inflammatory cytokines and postmyocardial infarction remodeling. Circ Res 94, 1543-1553. doi: 10.1161/01.RES.0000130526.20854.fa
123. Nonaka, H., Emoto, N., Ikeda, K., Fukuya, H., Rohman, M.S., Raharjo, S.B., Yagita, K., Okamura, H., and Yokoyama, M. (2001). Angiotensin II induces circadian gene expression of clock genes in cultured vascular smooth muscle cells. Circulation 104, 1746-1748
124. Oldenburg, O., Cohen, M.V., Yellon, D.M., and Downey, J.M. (2002). Mitochondrial K(ATP) channels: role in cardioprotection. Cardiovasc Res 55, 429-437. doi: S000863630200439X [pii]
125. Omar, M.A., Wang, L., and Clanachan, A.S. Cardioprotection by GSK-3 Inhibition: Role of Enhanced Glycogen Synthesis and Attenuation of Calcium Overload. Cardiovasc Res. doi: cvp421 [pii] 10.1093/cvr/cvp421
126. Opie, L.H., Commerford, P.J., Gersh, B.J., and Pfeffer, M.A. (2006). Controversies in ventricular remodelling. Lancet 367, 356-367
127. Petrosillo, G., Colantuono, G., Moro, N., Ruggiero, F.M., Tiravanti, E., Di Venosa, N., Fiore, T., and Paradies, G. (2009). Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening. Am J Physiol Heart Circ Physiol 297, H1487-1493. doi: 00163.2009 [pii] 10.1152/ajpheart.00163.2009
128. Pfeffer, M.A., and Braunwald, E. (1990). Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81, 1161-1172
129. Prasai, M.J., George, J.T., and Scott, E.M. (2008). Molecular clocks, type 2 diabetes and cardiovascular disease. Diab Vasc Dis Res 5, 89-95
130. Reddy, A.B., and Maywood, E.S. (2007). Circadian rhythms: per2bations in the liver clock. Curr Biol 17, R292-294. doi: 10.1016/j.cub.2007.02.031
131. Reddy, A.B., and Rey, G. (2014). Metabolic and nontranscriptional circadian clocks: eukaryotes. Annu Rev Biochem 83, 165-189. doi: 10.1146/annurev-biochem-060713-035623
132. Reick, M., Garcia, J.A., Dudley, C., and Mcknight, S.L. (2001). NPAS2: an analog of clock operative in the mammalian forebrain. Science 293, 506-509
133. Reimer, K.A., and Jennings, R.B. (1979). The wavefront phenomenon of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 40, 633-644
134. Reppert, S.M., and Weaver, D.R. (2002). Coordination of circadian timing in mammals. Nature 418, 935-941
135. Robinson, I., and Reddy, A.B. (2014). Molecular mechanisms of the circadian clockwork in mammals. FEBS Lett 588, 2477-2483. doi: 10.1016/j.febslet.2014.06.005
136. Rossi, F. (1986). The O2- -forming NADPH oxidase of the phagocytes: nature, mechanisms of activation and function. Biochim Biophys Acta 853, 65-89
137. Rotrosen, D. (1992). The respiratory burst oxidase. New York: Raven
138. Ruger, M., and Scheer, F.A. (2009). Effects of circadian disruption on the cardiometabolic system. Rev Endocr Metab Disord 10, 245-260. doi: 10.1007/s11154-009-9122-8
139. Sambandam, N., Morabito, D., Wagg, C., Finck, B.N., Kelly, D.P., and Lopaschuk, G.D. (2006). Chronic activation of PPARalpha is detrimental to cardiac recovery after ischemia. Am J Physiol Heart Circ Physiol 290, H87-95
140. Sancar, A. (2000). Cryptochrome: the second photoactive pigment in the eye and its role in circadian photoreception. Annu Rev Biochem 69, 31-67
141. Sangoram, A.M., Saez, L., Antoch, M.P., Gekakis, N., Staknis, D., Whiteley, A., Fruechte, E.M., Vitaterna, M.H., Shimomura, K., King, D.P., Young, M.W., Weitz, C.J., and Takahashi, J.S. (1998) Mammalian circadian autoregulatory loop: a timeless ortholog and mPer1 interact and negatively regulate CLOCK-BMAL1-induced transcription. Neuron 21, 1101-1113
142. Savopoulos, C., Ziakas, A., Hatzitolios, A., Delivoria, C., Kounanis, A., Mylonas, S., Tsougas, M., and Psaroulis, D. (2006). Circadian rhythm in sudden cardiac death: a retrospective study of 2,665 cases. Angiology 57, 197-204
143. Scadden, D.T. (2008). Circadian rhythms: stem cells traffic in time. Nature 452, 416-417. doi: 452416a [pii] 10.1038/452416a.
144. Schwertz, H., Carter, J.M., Abdudureheman, M., Russ, M., Buerke, U., Schlitt, A., Muller-Werdan, U., Prondzinsky, R., Werdan, K., and Buerke, M. (2007). Myocardial ischemia/reperfusion causes VDAC phosphorylation which is reduced by cardioprotection with a p38 MAP kinase inhibitor. Proteomics 7, 4579-4588. doi: 10.1002/pmic.200700734
145. Seal, J.B., and Gewertz, B.L. (2005). Vascular dysfunction in ischemia-reperfusion injury. Ann Vasc Surg 19, 572-584
146. Semenza, G.L. (2001). Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med 7, 345-350
147. Sephton, S.E., Sapolsky, R.M., Kraemer, H.C., and Spiegel, D. (2000). Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst 92, 994-1000
148. Shearman, L.P., Jin, X., Lee, C., Reppert, S.M., and Weaver, D.R. (2000). Targeted disruption of the mPer3 gene: subtle effects on circadian clock function. Mol Cell Biol 20, 6269-6275
149. Squires, C.E., Escobar, G.P., Payne, J.F., Leonardi, R.A., Goshorn, D.K., Sheats, N.J., Mains, I.M., Mingoia, J.T., Flack, E.C., and Lindsey, M.L. (2005). Altered fibroblast function following myocardial infarction. J Mol Cell Cardiol 39, 699-707
150. Stanley, W.C. (2004). Myocardial energy metabolism during ischemia and the mechanisms of metabolic therapies. J Cardiovasc Pharmacol Ther 9 Suppl 1, S31-45
151. Sun, Y., Kiani, M.F., Postlethwaite, A.E., and Weber, K.T. (2002). Infarct scar as living tissue. Basic Res Cardiol 97, 343-347
152. Sun, Z.S., Albrecht, U., Zhuchenko, O., Bailey, J., Eichele, G., and Lee, C.C. (1997). RIGUI, a putative mammalian ortholog of the Drosophila period gene. Cell 90, 1003-1011
153. Suzuki, K., Murtuza, B., Smolenski, R.T., Sammut, I.A., Suzuki, N., Kaneda, Y., and Yacoub, M.H. (2001). Overexpression of interleukin-1 receptor antagonist provides cardioprotection against ischemiareperfusion injury associated with reduction in apoptosis. Circulation 104, I308-I303
154. Takayama, T., Wada, A., Tsutamoto, T., Ohnishi, M., Fujii, M., Isono, T., and Horie, M. (2004). Contribution of vascular NAD(P)H oxidase to endothelial dysfunction in heart failure and the therapeutic effects of HMG-CoA reductase inhibitor. Circ J 68, 1067-1075
155. Taniyama, Y., and Griendling, K.K. (2003). Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 42, 1075-1081
156. Thresher, R.J., Vitaterna, M.H., Miyamoto, Y., Kazantsev, A., Hsu, D.S., Petit, C., Selby, C.P., Dawut, L., Smithies, O., Takahashi, J.S., and Sancar, A. (1998). Role of mouse cryptochrome blue-light photoreceptor in circadian photoresponses. Science 282, 1490-1494
157. Tong, H., Imahashi, K., Steenbergen, C., and Murphy, E. (2002). Phosphorylation of glycogen synthase kinase-3beta during preconditioning through a phosphatidylinositol-3-kinase--dependent pathway is cardioprotective. Circ Res 90, 377-379
158. Tsimakouridze, E.V., Straume, M., Podobed, P.S., Chin, H., Lamarre, J., Johnson, R., Antenos, M., Kirby, G.M., Mackay, A., Huether, P., Simpson, J.A., Sole, M., Gadal, G., and Martino, T.A. (2012). Chronomics of pressure overload-induced cardiac hypertrophy in mice reveals altered day/night gene expression and biomarkers of heart disease. Chronobiol Int 29, 810-821. doi: 10.3109/07420528.2012.691145
159. Tsinkalovsky, O., Rosenlund, B., Laerum, O.D., and Eiken, H.G. (2005). Clock gene expression in purified mouse hematopoietic stem cells. Exp Hematol 33, 100-107
160. Tsinkalovsky, O., Smaaland, R., Rosenlund, B., Sothern, R.B., Hirt, A., Steine, S., Badiee, A., Abrahamsen, J.F., Eiken, H.G., and Laerum, O.D. (2007). Circadian variations in clock gene expression of human bone marrow CD34+ cells. J Biol Rhythms 22, 140-150. doi: 22/2/140 [pii]
161. Tsuchiya, Y., Minami, I., Kadotani, H., and Nishida, E. (2005). Resetting of peripheral circadian clock by prostaglandin E2. EMBO Rep 6, 256-261
162. Tsujino, T., Naito, Y., Kawasaki, D., Okuda, S., Sakoda, T., Fujioka, Y., Sugaya, T., and Ohyanagi, M. (2005). Circadian expression of plasminogen activator inhibitor-1 in angiotensin II type 1a receptor knockout mice. Clin Exp Hypertens 27, 159-168
163. Vanhoutte, D., Schellings, M., Pinto, Y., and Heymans, S. (2006). Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window. Cardiovasc Res 69, 604-613
164. Vargo, J.M., Grachek, R.A., and Rockswold, G.L. (1999). Light deprivation soon after frontal brain trauma accelerates recovery from attentional deficits and promotes functional normalization of basal ganglia. J Trauma 47, 265-272; discussion 273-264
165. Vargo, J.M., Lai, H.V., and Marshall, J.F. (1998). Light deprivation accelerates recovery from frontal cortical neglect: relation to locomotion and striatal Fos expression. Behav Neurosci 112, 387-398
166. Vaughan, D.E. (2005). PAI-1 and atherothrombosis. J Thromb Haemost 3, 1879-1883
167. Virag, J.A., Anderson, E.J., Kent, S.D., Blanton, H.D., Johnson, T.L., Moukdar, F., Deantonio, J.H., Thayne, K., Ding, J.M., and Lust, R.M. (2013). Cardioprotection via preserved mitochondrial structure and function in the mPer2-mutant mouse myocardium. Am J Physiol Heart Circ Physiol 305, H477-483. doi: 10.1152/ajpheart.00914.2012
168. Virag, J.A., Dries, J.L., Easton, P.R., Friesland, A.M., Deantonio, J.H., Chintalgattu, V., Cozzi, E., Lehmann, B.D., Ding, J.M., and Lust, R.M. (2010). Attenuation of myocardial injury in mice with functional deletion of the circadian rhythm gene mPer2. Am J Physiol Heart Circ Physiol 298, H1088-1095. doi: 01280.2008 [pii] 10.1152/ajpheart.01280.2008
169. Virag, J.I., and Murry, C.E. (2003). Myofibroblast and endothelial cell proliferation during murine myocardial infarct repair. Am J Pathol 163, 2433-2440. doi: 10.1016/S0002-9440(10)63598-5
170. Viswambharan, H., Carvas, J.M., Antic, V., Marecic, A., Jud, C., Zaugg, C.E., Ming, X.F., Montani, J.P., Albrecht, U., and Yang, Z. (2007). Mutation of the circadian clock gene Per2 alters vascular endothelial function. Circulation 115, 2188-2195. doi: 10.1161/CIRCULATIONAHA.106.653303
171. Vukolic, A., Antic, V., Van Vliet, B.N., Yang, Z., Albrecht, U., and Montani, J.P. (2010). Role of mutation of the circadian clock gene Per2 in cardiovascular circadian rhythms. Am J Physiol Regul Integr Comp Physiol 298, R627-634. doi: 10.1152/ajpregu.00404.2009
172. Walters, J.F., Hampton, S.M., Deanfield, J.E., Donald, A.E., Skene, D.J., and Ferns, G.A. (2006). Circadian variation in endothelial function is attenuated in postmenopausal women. Maturitas 54, 294-303
173. Welbourn, C.R., Goldman, G., Paterson, I.S., Valeri, C.R., Shepro, D., and Hechtman, H.B. (1991). Pathophysiology of ischaemia reperfusion injury: central role of the neutrophil. Br J Surg 78, 651-655
174. Willich, S.N., Kulig, M., and Muller-Nordhorn, J. (2004). European survey on circadian variation of angina pectoris (ESCVA) in treated patients. Herz 29, 665-672
175. Wong, R., Aponte, A.M., Steenbergen, C., and Murphy, E. Cardioprotection leads to novel changes in the mitochondrial proteome. Am J Physiol Heart Circ Physiol 298, H75-91. doi: 00515.2009 [pii] 10.1152/ajpheart.00515.2009
176. Wu, L., and Reddy, A.B. (2014). Rethinking the clockwork: redox cycles and non-transcriptional control of circadian rhythms. Biochem Soc Trans 42, 1-10. doi: 10.1042/BST20130169
177. Xu, Y., Toh, K.L., Jones, C.R., Shin, J.Y., Fu, Y.H., and Ptacek, L.J. (2007). Modeling of a human circadian mutation yields insights into clock regulation by PER2. Cell 128, 59-70
178. Yagita, K., Yamaguchi, S., Tamanini, F., Van Der Horst, G.T., Hoeijmakers, J.H., Yasui, A., Loros, J.J., Dunlap, J.C., and Okamura, H. (2000). Dimerization and nuclear entry of mPER proteins in mammalian cells. Genes Dev 14, 1353-1363
179. Yagita, K., Yamanaka, I., Emoto, N., Kawakami, K., and Shimada, S. (2010). Real-time monitoring of circadian clock oscillations in primary cultures of mammalian cells using Tol2 transposonmediated gene transfer strategy. BMC Biotechnol 10, 3. doi: 10.1186/1472-6750-10-3
180. Yamakawa, M., Liu, L.X., Date, T., Belanger, A.J., Vincent, K.A., Akita, G.Y., Kuriyama, T., Cheng, S.H., Gregory, R.J., and Jiang, C. (2003). Hypoxia-inducible factor-1 mediates activation of cultured vascular endothelial cells by inducing multiple angiogenic factors. Circ Res 93, 664-673
181. Yang, X., Wood, P.A., Oh, E.Y., Du-Quiton, J., Ansell, C.M., and Hrushesky, W.J. (2008). Down regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm. Breast Cancer Res Treat. doi: 10.1007/s10549-008-0133-z
182. Young, M.E. (2006). The circadian clock within the heart: potential influence on myocardial gene expression, metabolism, and function. Am J Physiol Heart Circ Physiol 290, H1-16
183. Young, M.E., Razeghi, P., Cedars, A.M., Guthrie, P.H., and Taegtmeyer, H. (2001a). Intrinsic diurnal variations in cardiac metabolism and contractile function. Circ Res 89, 1199-1208
184. Young, M.E., Razeghi, P., and Taegtmeyer, H. (2001b). Clock genes in the heart: characterization and attenuation with hypertrophy. Circ Res 88, 1142-1150
185. Zhao, Z.Q., and Vinten-Johansen, J. (2006). Postconditioning: reduction of reperfusion-induced injury. Cardiovasc Res 70, 200-211
186. Zheng, B., Larkin, D.W., Albrecht, U., Sun, Z.S., Sage, M., Eichele, G., Lee, C.C., and Bradley, A. (1999). The mPer2 gene encodes a functional component of the mammalian circadian clock. Nature 400, 169-173